Works matching IS 10837159 AND DT 2011 AND VI 16 AND IP 5

Results: 24

Dramatic Response to Panitumumab and Bevacizumab in Metastatic Gallbladder Carcinoma.

Published in:

2011

By:

Riley, Elizabeth;
Carloss, Harry

Publication type:

Letter

All Nodes Lead to Chemo...

Published in:

Oncologist, 2011, v. 16, n. 5, p. 722, doi. 10.1634/theoncologist.2011-0118

By:

Schapira, Lidia;
Higgins, Michaela J.

Publication type:

Article

Short-Course Versus Standard Chemoradiation in T3 Rectal Cancer.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 717, doi. 10.1634/theoncologist.2011-0052

By:

Hong, Theodore S.;
Mamon, Harvey

Publication type:

Article

Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 708, doi. 10.1634/theoncologist.2010-0248

By:

Park, Susanna B.;
Lin, Cindy S. Y.;
Krishnan, Arun V.;
Goldstein, David;
Friedlander, Michael L.;
Kiernan, Matthew C.

Publication type:

Article

The Benefit of the Neutropenic Diet: Fact or Fiction?

Published in:

Oncologist, 2011, v. 16, n. 5, p. 704, doi. 10.1634/theoncologist.2011-0001

By:

Jubelirer, Steven J.

Publication type:

Article

Quantity, Design, and Scope of the Palliative Oncology Literature.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 694, doi. 10.1634/theoncologist.2010-0397

By:

Hui, David;
Parsons, Henrique A.;
Damani, Shamsha;
Fulton, Stephanie;
Jun Liu;
Evans, Avery;
De La Cruz, Maxine;
Bruera, Eduardo

Publication type:

Article

Desmoid Tumors: Clinical Features and Treatment Options for Advanced Disease.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 682, doi. 10.1634/theoncologist.2010-0281

By:

Kasper, Bernd;
StrBel, Philipp;
Hohenberger, Peter

Publication type:

Article

Role of Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: A Reassessment Based on New Data.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 672, doi. 10.1634/theoncologist.2010-0150

By:

le p Choux, Cécile

Publication type:

Article

Survival of Patients with Chronic Myelocytic Leukemia: Comparisons of Estimates from Clinical Trial Settings and Population-Based Cancer Registries.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 663, doi. 10.1634/theoncologist.2010-0393

By:

Pulte, Dianne;
Gondos, Adam;
Redaniel, Maria Theresa;
Brenner, Hermann

Publication type:

Article

The Role of Bisphosphonates in Multiple Myeloma: Mechanisms, Side Effects, and the Future.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 651, doi. 10.1634/theoncologist.2010-0225

By:

Pozzi, Samantha;
Raje, Noopur

Publication type:

Article

Postoperative Radiotherapy for Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single Institution.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 641, doi. 10.1634/theoncologist.2010-0343

By:

Honghai Dai;
Zhouguang Hui;
Wei Ji;
Jun Liang;
Jima Lu;
Guangfei Ou;
Zongmei Zhou;
Qinfu Feng;
Zefen Xiao;
Dongfu Chen;
Hongxing Zhang;
Weibo Yin;
Jie He;
Luhua Wang

Publication type:

Article

Patient-Reported Outcomes in a Phase III Study of Everolimus Versus Placebo in Patients with Metastatic Carcinoma of the Kidney That Has Progressed on Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 632, doi. 10.1634/theoncologist.2010-0299

By:

Beaumont, Jennifer L.;
Butt, Zeeshan;
Baladi, Jeanfrancois;
Motzer, Robert J.;
Haas, Tomas;
Hollaender, Norbert;
Kay, Andrea;
Cella, David

Publication type:

Article

An Argument for the Universal Prophylaxis of Hepatitis B Infection in Patients Receiving Rituximab: A 7-Year Institutional Experience of Hepatitis Screening.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 579, doi. 10.1634/theoncologist.2010-0182

By:

Leung, Christopher;
Tsoi, Edward;
Burns, Gareth;
Sievert, William

Publication type:

Article

Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging--Defined Poor-Prognosis Locally Advanced Rectal Cancer: The AVACROSS Study.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 614, doi. 10.1634/theoncologist.2010-0285

By:

Nogué, Miguel;
Salud, Antonieta;
Vicente, Pilar;
Arriví, Antonio;
Roca, José María;
Losa, Ferran;
Ponce, José;
Safont, María José.;
Guasch, Inmaculada;
Moreno, Isabel;
Ruiz, Ana;
Pericay, Carles

Publication type:

Article

Diagnosis and Treatment of Gastroenteropancreatic Neuroendocrine Tumors: Current Data on a Prospectively Collected, Retrospectively Analyzed Clinical Multicenter Investigation.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 602, doi. 10.1634/theoncologist.2011-0002

By:

Niederle, Martin B.;
Niederle, Bruno

Publication type:

Article

Transarterial Chemoembolization and Selective Internal Radiation for the Treatment of Patients with Metastatic Neuroendocrine Tumors: A Comparison of Efficacy and Cost.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 594, doi. 10.1634/theoncologist.2010-0292

By:

Whitney, Ryan;
V-Lek, Vlatimil;
Fages, Joan Falco;
Garcia, Agustin;
Narayanan, Govindarajan;
Tatum, Cliff;
Hahl, Mike;
Martin Ii, Robert C. G.

Publication type:

Article

Follicular Adenoma and Carcinoma of the Thyroid Gland.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 585, doi. 10.1634/theoncologist.2010-0405

By:

Mchenry, Christopher R.;
Phitayakorn, Roy

Publication type:

Article

Gender-Specific Acute Organ Toxicity during Intensified Preoperative Radiochemotherapy for Rectal Cancer.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 621, doi. 10.1634/theoncologist.2010-0414

By:

Wolff, Hendrik A.;
Conradi, Lena-Christin;
Schirmer, Markus;
Beissbarth, Tim;
Sprenger, Thilo;
Rave-Fränk, Margret;
Hennies, Steffen;
Hess, Clemens F.;
Becker, Heinz;
Christiansen, Hans;
Liersch, Torsten

Publication type:

Article

Current Status of Src Inhibitors in Solid Tumor Malignancies.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 566, doi. 10.1634/theoncologist.2010-0408

By:

Puls, Lauren N.;
Eadens, Matthew;
Messersmith, Wells

Publication type:

Article

Continued Use of Trastuzumab Beyond Disease Progression in the National Comprehensive Cancer Network: Should We Practice Ahead of the Evidence?

Published in:

Oncologist, 2011, v. 16, n. 5, p. 559, doi. 10.1634/theoncologist.2010-0360

By:

Wong, Yu-Ning;
Ottesen, Rebecca A.;
Hughes, Melissa E.;
Niland, Joyce C.;
Theriault, Richard;
Edge, Stephen B.;
Blayney, Douglas;
Weeks, Jane C.

Publication type:

Article

Predictive Value of In Vitro Mutation Data to Guide Second-Generation Tyrosine Kinase Inhibitor Selection: Ready for Prime Time?

Published in:

Oncologist, 2011, v. 16, n. 5, p. 554, doi. 10.1634/theoncologist.2010-0297

By:

Silver, Richard T.

Publication type:

Article

Sunitinib in Metastatic Renal Cell Carcinoma: Recommendations for Management of Noncardiovascular Toxicities.

Published in:

Oncologist, 2011, v. 16, n. 5, p. 543, doi. 10.1634/theoncologist.2010-0263

By:

Kollmannsberger, Christian;
Bjarnason, Georg;
Burnett, Patrick;
Creel, Patricia;
Davis, Mellar;
Dawson, Nancy;
Feldman, Darren;
George, Suzanne;
Hershman, Jerome;
Lechner, Thomas;
Potter, Amy;
Raymond, Eric;
Treister, Nathaniel;
Wood, Laura;
Wu, Shenhong;
Bukowski, Ronald

Publication type:

Article

The High Tide of Cancer Research in Europe.

Published in:

2011

By:

Johnston, Patrick G.;
Pinedo, H. M.

Publication type:

Editorial

Reflections.

Published in:: Oncologist, 2011, v. 16, n. 5, p. 1, doi. 10.1634/theoncologist.2011-5001
Publication type:: Article